Global Next-Generation Sequencing (NGS) Market Size, Status and Forecast 2022 - Roche Sequencing, Pacific Biosciences, BGI

Qyresearchreports include new market research report "Global Next-Generation Sequencing (NGS) Market Size, Status and Forecast 2022" to its huge collection of research reports.

The global Next-Generation Sequencing (NGS) market is forever evolving, and hence several factors will define the future prospects. This report has been created to serve as a dependable business document for the stakeholders attached to the value chain of the global Next-Generation Sequencing (NGS) market, analyzing all the important factors, catching the latest trends, and estimating the future scenario. The report has been prepared using conventional research methodologies such as SWOT Analysis and Porter’s Five Forces.

To Get Sample Copy of Report visit @ http://www.qyresearchreports.com/sample/sample.php?rep_id=1184736&type=E

In order to gauge the potential of various segments of product, application, and end-use, the report takes each one at a time and provides future prospects. This report on the global Next-Generation Sequencing (NGS) market also takes stocks of various regions, identifies the most lucrative country-wide markets, and takes notes of the level of competition coming from regional players. To evaluate market size, the report has considered several data points such as market split and regional split on the basis of source, product and qualitative inputs from primary responses have been taken into account to deduce suitable market estimates. The forecasts presented in this report calculates the total revenue that is anticipated to be generated across the Next-Generation Sequencing (NGS) market over forecast period 2017-2022.

In order to form a picture of the competitive landscape, the report has profiled a number of leading players in the global Next-Generation Sequencing (NGS) market. For each player, the report overviews their geographical reach, estimates share of the pie, and analyzes the recent strategic developments such as acquisitions and agreements, marketing strategies, and customer relationship.

Table of Contents

Global Next-Generation Sequencing (NGS) Market Size, Status and Forecast 2022
1 Industry Overview
1.1 Next-Generation Sequencing (NGS) Market Overview
1.1.1 Next-Generation Sequencing (NGS) Product Scope
1.1.2 Market Status and Outlook
1.2 Global Next-Generation Sequencing (NGS) Market Size and Analysis by Regions
1.2.1 USA
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Digital Out of Home Market by Type
1.3.1 454-Sequencing
1.3.2 Illumina Sequencing
1.3.3 Others
1.4 Next-Generation Sequencing (NGS) Market by End Users/Application
1.4.1 Oncology
1.4.2 Hereditary Disease Detection
1.4.3 Life Science
1.4.4 Other Applications
1.5 De novo Genome assembly market analysis
1.6 Non-human whole genome sequencing

Browse Complete Report with TOC @ http://www.qyresearchreports.com/report/global-next-generation-sequencing-ngs-market-size-status-and-forecast-2022.htm

2 Global Next-Generation Sequencing (NGS) Competition Analysis by Players
2.1 Next-Generation Sequencing (NGS) Market Size (Value) by Players (2015-2016)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Thermo Fisher Scientific
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Next-Generation Sequencing (NGS) Revenue (Value) 2012-2017
3.1.5 Recent Developments
3.2 Illumina
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Next-Generation Sequencing (NGS) Revenue (Value) 2012-2017
3.2.5 Recent Developments
3.3 Roche Sequencing
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Next-Generation Sequencing (NGS) Revenue (Value) 2012-2017
3.3.5 Recent Developments
3.4 Pacific Biosciences
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Next-Generation Sequencing (NGS) Revenue (Value) 2012-2017
3.4.5 Recent Developments
3.5 BGI
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Next-Generation Sequencing (NGS) Revenue (Value) 2012-2017
3.5.5 Recent Developments
3.6 Novo gene
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Next-Generation Sequencing (NGS) Revenue (Value) 2012-2017
3.6.5 Recent Developments
3.7 Biomarker
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Next-Generation Sequencing (NGS) Revenue (Value) 2012-2017
3.7.5 Recent Developments
3.8 Roche
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Next-Generation Sequencing (NGS) Revenue (Value) 2012-2017
3.8.5 Recent Developments
3.9 Daan Gene
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Next-Generation Sequencing (NGS) Revenue (Value) 2012-2017
3.9.5 Recent Developments
3.10 Berry Genomics
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Next-Generation Sequencing (NGS) Revenue (Value) 2012-2017
3.10.5 Recent Developments
3.11 Majorbio
3.12 CapitalBio Corporation
3.13 Anoroad
3.14 Zhongke Zixin

About Us
QYReseachReports.com delivers the latest strategic market intelligence to build a successful business footprint in China. Our syndicated and customized research reports provide companies with vital background information of the market and in-depth analysis on the Chinese trade and investment framework, which directly affects their business operations. Reports from QYReseachReports.com feature valuable recommendations on how to navigate in the extremely unpredictable yet highly attractive Chinese market.

Contact Us
1820 Avenue
M Suite #1047
Brooklyn, NY 11230
United States
Toll Free: 866-997-4948 (USA-CANADA)
Tel: +1-518-621-2074
Web: http://www.qyresearchreports.com
Email: sales@qyresearchreports.com

This release was published on openPR.